Action Roche - 0QQ6

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

229,20

Prix Achat

0,00

Prix Vente

0,00

Volume échangé

651

0,00 Fourchette du Jour 0,00

229,20 Plage de 52 semaines 229,20

Cap du marché

Clôture Veille

229,20

Ouverture

Dernière Transaction

134

272.4

(O)

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

4 792

Actions en circulation

0,00

Rendement du Dividende

Ratio Cours sur Bénéfices

0,00

Bénéfice par action (BPA)

Chiffre d'affairess

58,72B

Bénéfice net

11,5B

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.roche.com

Siège social

Basel, Che

Fondé

Roche Holding Ag est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker 0QQ6. Le dernier cours de clôture d'Roche était de CHF229,20. Au cours de la dernière année, les actions de Roche ont été négociées dans une fourchette de prix de CHF 229,20 à CHF 229,20.

Roche compte actuellement 0 actions en circulation.

Roche’s Phase IIb study of prasinezumab missed primary endpoint, but suggests possible benefit in early-stage Parkinson’s disease

Roche’s Phase IIb study of prasinezumab missed primary endpoint, but suggests possible benefit in early-stage Parkinson’s disease PADOVA study showed numerical delay in motor progression and...

Roche transforms mass spectrometry diagnostics with launch of cobas® Mass Spec solution

Roche transforms mass spectrometry diagnostics with launch of cobas® Mass Spec solution Roche launches its cobas® Mass Spec solution, bringing mass spectrometry to the routine clinical labClinical...

Roche’s Vabysmo prefilled syringe (PFS) approved in the EU for three retinal conditions that can cause blindness

Roche’s Vabysmo prefilled syringe (PFS) approved in the EU for three retinal conditions that can cause blindness Vabysmo PFS is the first and only prefilled syringe containing a bispecific...

Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems, enhancing laboratory efficiency and testing capabilities

Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems, enhancing laboratory efficiency and testing capabilities The new cobas 6800/8800 systems 2.0 enhances throughput, run...

New and updated data for Roche's fixed-duration Columvi and Lunsumio at ASH 2024 reinforce their potential to improve outcomes for people with lymphoma

New and updated data for Roche's fixed-duration Columvi and Lunsumio at ASH 2024 reinforce their potential to improve outcomes for people with lymphoma Long-term data confirm fixed-duration...

Roche commences tender offer for all shares of Poseida Therapeutics, Inc. for $9.00 per share in cash, plus a non-tradeable contingent value right for up to $4.00 per share in cash

Roche commences tender offer for all shares of Poseida Therapeutics, Inc. for $9.00 per share in cash, plus a non-tradeable contingent value right for up to $4.00 per share in cash Basel, 9...

Five-year results confirm Roche’s Polivy combination therapy as new standard of care for previously untreated aggressive lymphoma

Five-year results confirm Roche’s Polivy combination therapy as new standard of care for previously untreated aggressive lymphoma Exploratory long-term follow-up analysis of the phase III POLARIX...

FDA accepts supplemental Biologics License Application for Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma

FDA accepts supplemental Biologics License Application for Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma Application is based on data from the...

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies Acquisition supports Roche’s Pharma Strategy and...

Roche reports update on Phase III SKYSCRAPER-01 study results

Roche reports update on Phase III SKYSCRAPER-01 study results Basel, 26 November 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) reports an update on the phase III SKYSCRAPER-01 study, evaluating...

Période	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	229.2	229.2	229.2	937	229.2	DE
4	229.2	229.2	229.2	5535	229.2	DE
12	229.2	229.2	229.2	4792	229.2	DE
26	229.2	229.2	229.2	4445	229.2	DE
52	229.2	229.2	229.2	5209	229.2	DE
156	229.2	229.2	229.2	6094	229.2	DE
260	229.2	229.2	229.2	4941	229.2	DE

0QQ6 - Frequently Asked Questions (FAQ)

What is the current Roche share price?

The current share price of Roche is CHF 229,20

What is the 1 year trading range for Roche share price?

Roche has traded in the range of CHF 229,20 to CHF 229,20 during the past year

What is the reporting currency for Roche?

Roche reports financial results in CHF

What is the latest annual turnover for Roche?

The latest annual turnover of Roche is CHF 58,72B

What is the latest annual profit for Roche?

The latest annual profit of Roche is CHF 11,5B

What is the registered address of Roche?

The registered address for Roche is GRENZACHERSTRASSE 124, BASEL, 4070

What is the Roche website address?

The website address for Roche is www.roche.com

Which industry sector does Roche operate in?

Roche operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
TCFTheracryf Plc	0,725p (38,10%)	7,56M
NMTNeometals Ltd	3,50p (27,27%)	346,81k
SCHOScholium Group Plc	44,00p (25,71%)	30,65k
FABFusion Antibodies Plc	10,15p (24,54%)	3,34M
PYXPyx Resources Limited	3,49p (22,24%)	8,43k
TM1Technology Minerals Plc	0,125p (-24,24%)	37,21M
QUIZQuiz Plc	0,70p (-18,60%)	3,67M
SYMESupply@me Capital Plc	0,003p (-17,81%)	168,35M
OBDOxford Biodynamics Plc	1,20p (-14,29%)	827,83k
ZENZenith Energy Ltd.	5,25p (-13,93%)	5,39M
TRPTower Resources Plc	0,0395p (5,33%)	539,51M
CPXCap-xx Limited	0,1825p (1,39%)	494M
NTVONativo Resources Plc	0,0019p (0,00%)	320,16M
DGIDg Innovate Plc	0,0225p (-13,46%)	208,21M
ENETEthernity Networks Ltd	0,1125p (2,27%)	207,56M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Roche Holding Ag (0QQ6) Cours

Roche Holding Ag (0QQ6)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Roche Holding Ag

0QQ6 Dernières nouvelles

0QQ6 - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application